Verastem Oncology to Participate in the H.C. Wainwright Global Life Sciences Conference
Verastem, a biopharmaceutical company focused on cancer treatment, will participate in the virtual H.C. Wainwright Global Life Sciences Conference. The fireside chat will be accessible for on-demand listening starting March 9, 2021, at 7:00 a.m. EST. Interested individuals can find the webcast in the 'Media' section of Verastem's website under 'Events & Presentations.'
Verastem's mission is to develop new medicines targeting critical pathways that promote cancer cell survival and tumor growth, with a focus on RAF/MEK and FAK inhibition.
- None.
- None.
Verastem, Inc. (Nasdaq:VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed to advancing new medicines for patients battling cancer, today announced that the Company will participate in the virtual H.C. Wainwright Global Life Sciences Conference. The fireside chat will be made available for on-demand listening beginning Tuesday, March 9, 2021 at 7:00 a.m. EST.
The webcast of the fireside chat will be available on the “Media” section of the Company’s website at www.verastem.com under “Events & Presentations”.
About Verastem Oncology
Verastem Oncology (Nasdaq: VSTM) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, including RAF/MEK inhibition and focal adhesion kinase (FAK) inhibition. For more information, please visit www.verastem.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210302005061/en/
FAQ
When is Verastem's fireside chat at the H.C. Wainwright Global Life Sciences Conference?
Where can I watch Verastem's fireside chat?
What is Verastem's focus in cancer treatment?
What stock symbol represents Verastem?
